🇺🇸 FDA
Patent

US 10001495

Blood factor monitoring assay and uses thereof

granted A61KA61K38/4846

Quick answer

US patent 10001495 (Blood factor monitoring assay and uses thereof) held by BIOVERATIV THERAPEUTICS INC. expires Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BIOVERATIV THERAPEUTICS INC.
Grant date
Tue Jun 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 14 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K38/4846